Camptothecin .beta.-alanine esters with topoisomerase I inhibition

Wall, M., Wani, M., Manikumar, G., Balasubramanian, N., & Vyas, D. (2001). Camptothecin .beta.-alanine esters with topoisomerase I inhibition. (U.S. Patent No. 6288072). http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=6288072

Abstract

.beta.-Alanine esters of camptothecin compounds which areeffective anti-tumor compounds are disclosed. These compoundsinhibit the enzyme topoisomerase I and may alkylate DNA of theassociated topoisomerase I-DNA cleavable complex.

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers
Article

Far-right and Jihadi terrorism within the United States
Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders
Article

Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene